Literature DB >> 2834358

A 10-kDa cyanogen bromide fragment from the epidermal growth factor homology domain of rabbit thrombomodulin contains the primary thrombin binding site.

S Kurosawa1, D J Stearns, K W Jackson, C T Esmon.   

Abstract

We have isolated a fragment (approximately equal to 10 kDa) of thrombomodulin containing the fifth and sixth epidermal growth factor (EGF)-like regions which retains thrombin binding capacity. The amino-terminal sequence of a 50-kDa active fragment of thrombomodulin derived from elastase proteolysis begins 11 residues before the first EGF-like structure of native thrombomodulin. Subsequent digestion with cyanogen bromide yields a 10-kDa thrombin binding fragment. The amino-terminal sequence of this fragment starts at the fifth EGF-like structure (Phe407). The amino acid composition suggests that this fragment contains the fifth and sixth EGF-like structures with a total of approximately 77 residues. This fragment lacks cofactor activity, but acts as a competitive inhibitor for protein C activation (Ki = 8.6 +/- 1.4 nM). We propose that the fifth and sixth EGF-like structures contain the thrombin binding site of thrombomodulin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834358

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Molecular basis of loss-of-function mutations in the glp-1 gene of Caenorhabditis elegans.

Authors:  V Kodoyianni; E M Maine; J Kimble
Journal:  Mol Biol Cell       Date:  1992-11       Impact factor: 4.138

2.  Mutations in the fourth EGF-like domain affect thrombomodulin-induced changes in the active site of thrombin.

Authors:  Julia R Koeppe; Muneera A Beach; Abel Baerga-Ortiz; S Jordan Kerns; Elizabeth A Komives
Journal:  Biochemistry       Date:  2008-09-20       Impact factor: 3.162

Review 3.  The multiple roles of epidermal growth factor repeat O-glycans in animal development.

Authors:  Amanda R Haltom; Hamed Jafar-Nejad
Journal:  Glycobiology       Date:  2015-07-14       Impact factor: 4.313

4.  Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926.

Authors:  A Beretz; J M Freyssinet; J Gauchy; D A Schmitt; C Klein-Soyer; C J Edgell; J P Cazenave
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

5.  Thrombomodulin Binding Selects the Catalytically Active Form of Thrombin.

Authors:  Lindsey D Handley; Nicholas A Treuheit; Varun J Venkatesh; Elizabeth A Komives
Journal:  Biochemistry       Date:  2015-10-26       Impact factor: 3.162

Review 6.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

Review 7.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

8.  Thrombin inhibition by cyclic peptides from thrombomodulin.

Authors:  J C Lougheed; C L Bowman; D P Meininger; E A Komives
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

9.  Identification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: potential regulation of functionality by glycosyltransferase competition for serine474.

Authors:  B Gerlitz; T Hassell; C J Vlahos; J F Parkinson; N U Bang; B W Grinnell
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

10.  A fully active catalytic domain of bovine aspartyl (asparaginyl) beta-hydroxylase expressed in Escherichia coli: characterization and evidence for the identification of an active-site region in vertebrate alpha-ketoglutarate-dependent dioxygenases.

Authors:  S Jia; K McGinnis; W J VanDusen; C J Burke; A Kuo; P R Griffin; M K Sardana; K O Elliston; A M Stern; P A Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.